Search by Drug Name or NDC
NDC 39822-0151-01 Liothyronine Sodium 10 ug/mL Details
Liothyronine Sodium 10 ug/mL
Liothyronine Sodium is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by XGen Pharmaceuticals DJB, Inc.. The primary component is LIOTHYRONINE SODIUM.
Product Information
| NDC | 39822-0151 |
|---|---|
| Product ID | 39822-0151_02f79412-2198-a8af-e063-6394a90a0853 |
| Associated GPIs | 28100020102020 |
| GCN Sequence Number | 016661 |
| GCN Sequence Number Description | liothyronine sodium VIAL 10 MCG/ML INTRAVEN |
| HIC3 | P3A |
| HIC3 Description | THYROID HORMONES |
| GCN | 28941 |
| HICL Sequence Number | 002850 |
| HICL Sequence Number Description | LIOTHYRONINE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Liothyronine Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Liothyronine Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | ug/mL |
| Substance Name | LIOTHYRONINE SODIUM |
| Labeler Name | XGen Pharmaceuticals DJB, Inc. |
| Pharmaceutical Class | Triiodothyronine [CS], l-Triiodothyronine [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076923 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 39822-0151-01 (39822015101)
| NDC Package Code | 39822-0151-1 |
|---|---|
| Billing NDC | 39822015101 |
| Package | 1 VIAL in 1 CARTON (39822-0151-1) / 1 mL in 1 VIAL |
| Marketing Start Date | 2005-08-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |